Filing Details
- Accession Number:
- 0000874015-13-000089
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-07-22 19:51:46
- Reporting Period:
- 2013-07-18
- Filing Date:
- 2013-07-22
- Accepted Time:
- 2013-07-22 19:51:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
874015 | Isis Pharmaceuticals Inc | ISIS | Pharmaceutical Preparations (2834) | 330336973 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
897667 | T Stanley Crooke | C/O Isis Pharmaceuticals, Inc. 2855 Gazelle Court Carlsbad CA 92010 | Chairman And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-07-18 | 10,000 | $11.12 | 11,661 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-07-18 | 10,000 | $30.20 | 1,661 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-07-18 | 10,000 | $11.12 | 11,661 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-07-18 | 10,000 | $30.02 | 1,661 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-07-19 | 2,200 | $15.38 | 3,861 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-07-19 | 2,200 | $31.40 | 1,661 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-07-19 | 10,000 | $15.38 | 11,661 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-07-19 | 10,000 | $30.87 | 1,661 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-07-19 | 10,000 | $15.38 | 11,661 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-07-19 | 10,000 | $30.19 | 1,661 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-07-22 | 10,000 | $15.38 | 11,661 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-07-22 | 10,000 | $30.53 | 1,661 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-07-22 | 8,115 | $15.38 | 9,776 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-07-22 | 8,115 | $31.02 | 1,661 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-07-22 | 1,885 | $11.12 | 3,546 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-07-22 | 1,885 | $31.02 | 1,661 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-07-18 | 20,000 | $0.00 | 20,000 | $11.12 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-07-19 | 22,200 | $0.00 | 22,200 | $15.38 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-07-22 | 18,115 | $0.00 | 18,115 | $15.38 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-07-22 | 1,885 | $0.00 | 1,885 | $11.12 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
98,740 | 2011-01-02 | 2014-01-01 | No | 4 | M | Direct |
18,115 | 2012-01-02 | 2015-01-01 | No | 4 | M | Direct |
0 | 2012-01-02 | 2015-01-01 | No | 4 | M | Direct |
96,855 | 2011-01-02 | 2014-01-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 174 | Indirect | By Wife |
Common Stock | 775,391 | Indirect | By Trust |
Footnotes
- Acquired as a result of exercising a stock option that was scheduled to expire on 1/1/14. The purchase and sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 6/27/12.
- Acquired as a result of exercising a stock option that was scheduled to expire on 1/1/15. The purchase and sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 2/4/13.